EXMceuticals (FRA:9OM1) Long-Term Capital Lease Obligation : €0.01 Mil (As of Mar. 2021)

View and export this data going back to 2015. Start your Free Trial

What is EXMceuticals Long-Term Capital Lease Obligation?

EXMceuticals's Long-Term Capital Lease Obligation for the quarter that ended in Mar. 2021 was €0.01 Mil.

EXMceuticals's quarterly Long-Term Capital Lease Obligation declined from Sep. 2020 (€0.02 Mil) to Dec. 2020 (€0.02 Mil) and declined from Dec. 2020 (€0.02 Mil) to Mar. 2021 (€0.01 Mil).

EXMceuticals's annual Long-Term Capital Lease Obligation stayed the same from Jun. 2018 (€0.00 Mil) to Jun. 2019 (€0.00 Mil) but then increased from Jun. 2019 (€0.00 Mil) to Jun. 2020 (€0.02 Mil).

EXMceuticals Long-Term Capital Lease Obligation Historical Data

The historical data trend for EXMceuticals's Long-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

EXMceuticals Long-Term Capital Lease Obligation Chart

EXMceuticals Annual Data

Trend

Jun11

Jun12

Jun13

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Long-Term Capital Lease Obligation

Get a 7-Day Free Trial

0.02

EXMceuticals Quarterly Data
	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21
Long-Term Capital Lease Obligation	Get a 7-Day Free Trial															-	0.02	0.02	0.02	0.01

EXMceuticals (FRA:9OM1) Long-Term Capital Lease Obligation Explanation

Long-Term Capital Lease Obligation are the amount due for long-term asset lease agreements that are nearly equivalent to asset purchases. Capital lease obligations are installment payments that constitute a payment of principal plus interest for the capital lease. The Short-Term Capital Lease Obligation is the portion of a Long-Term Capital Lease Obligation that is due over the next year.

Under US Generally Accepted Accounting Principles (GAAP), a capital lease is essentially equivalent to a purchase by the lessee if it meets the following criteria:

1. Ownership of the asset is transferred to the lessee at the end of the lease term;
2. The lease contains a bargain purchase option to buy the equipment at less than fair market value;
3. The lease term equals or exceeds 75% of the asset's estimated useful life;
4. The present value of the lease payments equals or exceeds 90% of the total original cost of the equipment.

EXMceuticals Long-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of EXMceuticals's Long-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

EXMceuticals (FRA:9OM1) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » EXMceuticals Inc (FRA:9OM1) » Definitions » Long-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

N/A

Address

421 7th Avenue S.W., 30th Floor, Calgary, AB, CAN, T2P 4K9

Website

http://www.exmceuticals.com

EXMceuticals Inc is a bio-science company that believes in the potential health and wellness benefits of hemp and cannabis. EXM is an emerging player in the market, with ambition and potential to become the suppliers of highest-grade cannabis ingredients. It is creating an industrial-scale, GMP, Pharmaceutical Grade Extraction and Refining facility inside the European Union, near Lisbon Portugal. It has an existing and licensed cannabis R&D facility and pilot refinery in Lisbon Portugal. EXM is targeting the B2B marketplace and will supply pure ingredients and API's to the pharmaceutical, medicinal and wellness industry.

EXMceuticals (FRA:9OM1) Headlines

No Headlines